About Scinai
Scinai is a company based in Jerusalem (Israel) founded in 2023.. The company has 31 employees as of December 31, 2024. Scinai has completed 1 acquisition, including PinCell. Scinai offers products and services including NanoAbs and CDMO Services. Scinai operates in a competitive market with competitors including KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
- Headquarter Jerusalem, Israel
- Employees 31 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Scinai Immunotherapeutics Ltd. Sponsored Adr
-
Annual Revenue
$661.12 K0as on Dec 31, 2024
-
Net Profit
$4.82 M174.38as on Dec 31, 2024
-
EBITDA
$-7.02 M23.48as on Dec 31, 2024
-
Latest Funding Round
$1.69 M (USD), Post-IPO
Dec 29, 2023
- Investors
-
Employee Count
31
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Scinai
Scinai is a publicly listed company on the NASDAQ with ticker symbol SCNI in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Scinai
Scinai offers a comprehensive portfolio of products and services, including NanoAbs and CDMO Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Antibodies targeting inflammatory diseases for therapeutic use
Contract development and manufacturing for biopharmaceutical processes
Unlock access to complete
Unlock access to complete
Funding Insights of Scinai
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $1.7M
-
First Round
First Round
(03 Oct 2023)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Post-IPO - Scinai | Valuation |
investors |
|
| Nov, 2023 | Amount | Grant - Scinai | Valuation |
investors |
|
| Oct, 2023 | Amount | Post-IPO - Scinai | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Scinai
Scinai has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Israel Innovation Authority. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Business development in Israel is supported by a government organization.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Scinai
Scinai has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include PinCell. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of anti-inflammatory therapy for the treatment skin diseases
|
2008 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Scinai
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Scinai Comparisons
Competitors of Scinai
Scinai operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| domain | founded_year | HQ Location |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| domain | founded_year | HQ Location |
Integrated biologics development and manufacturing are provided as a CDMO.
|
|
| domain | founded_year | HQ Location |
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
|
|
| domain | founded_year | HQ Location |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| domain | founded_year | HQ Location |
Vaccines and biologics are developed and manufactured by IDT Biologika.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Scinai
Frequently Asked Questions about Scinai
When was Scinai founded?
Scinai was founded in 2023.
Where is Scinai located?
Scinai is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
How many employees does Scinai have?
As of Dec 31, 2024, the latest employee count at Scinai is 31.
What is the annual revenue of Scinai?
Annual revenue of Scinai is $661.12K as on Dec 31, 2024.
What does Scinai do?
Scinai Immunotherapeutics is a company that enables companies to go beyond carbon accounting and implement cost-effective carbon reduction strategies. They provide a decarbonization platform that helps companies take action towards reducing their carbon footprint.
Who are the top competitors of Scinai?
Scinai's top competitors include KBI Biopharma, Aldevron and Ovagen.
What products or services does Scinai offer?
Scinai offers NanoAbs and CDMO Services.
Is Scinai publicly traded?
Yes, Scinai is publicly traded on NASDAQ under the ticker symbol SCNI.
How many acquisitions has Scinai made?
Scinai has made 1 acquisition, including PinCell.
Who are Scinai's investors?
Scinai has 1 investor. Key investors include Israel Innovation Authority.
What is Scinai's ticker symbol?
The ticker symbol of Scinai is SCNI on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.